AI radiology triage: Aidoc vs Harrison.ai vs RapidAI

Choosing a radiology triage workflow

Radiology triage software analyzes eligible studies for suspected findings and brings relevant cases to professional attention. This comparison concerns worklist priority and notifications, rather than autonomous reporting or advice to patients. Aidoc, Harrison.ai and RapidAI cover different study types and clinical pathways, so a shortlist should begin with the imaging workload that needs prioritization.

Aidoc Radiology

Aidoc Radiology connects AI findings with the systems radiologists already use. Its centralized Widget provides results from multiple algorithms, while PACS integration can mark triage findings directly in the worklist. This gives an imaging department a shared interaction model instead of a separate interface for every algorithm. The broader aiOS platform also links radiology workflows with downstream team communication, making Aidoc relevant when the operational problem extends from noticing an urgent study to informing the people who need to respond. Its portfolio includes several imaging categories and partner products, but that breadth should be read as a procurement menu rather than an assumption that every algorithm is included or has identical regulatory status. Aidoc is a strong organizational fit for a hospital planning several AI pathways under one platform. The exact study-routing rules, findings shown and interfaces depend on the licensed algorithms and institution-specific configuration. The radiologist remains responsible for professional interpretation of the study.

Harrison.ai Comprehensive Care

Harrison.ai Comprehensive Care is the current US marketing name for Annalise Critical Care AI. It focuses on suspected findings in chest X-rays and non-contrast head CT, giving it a more defined imaging scope than a general enterprise algorithm platform. The current US page describes a finding list presented in a resizable no-click overlay alongside PACS and RIS workflows. Findings can be grouped by priority, and thresholds can be configured for individual findings to match the clinical workflow. That combination is relevant to hospitals and teleradiology providers seeking to bring selected routine or unexpected studies forward for review without forcing radiologists into a separate reporting environment. Harrison.ai also markets broader decision-support products globally, but their larger finding counts do not define the US triage package. The useful procurement object is the specific Comprehensive Care version and intended use in the relevant jurisdiction. Its role is to flag suspected findings and support prioritization; it does not turn an unflagged examination into a confirmed normal result.

RapidAI Rapid ICH

RapidAI Rapid ICH concentrates on suspected intracranial hemorrhage in non-contrast head CT. Its technical description links image analysis to notifications delivered through PACS, email and the Rapid mobile app, helping the responsible team become aware of a study requiring review. This is a narrower starting point than a chest-X-ray-plus-head-CT suite and can fit a stroke or neurocritical network that already organizes care around RapidAI. The current hemorrhage portfolio also describes Hyperdensity, SDH, MLS and other assessment products. Their adjacency is useful when the buyer wants more than the initial alert, but the modules should remain distinct: Rapid ICH notification is not automatically the same entitlement as quantitative hemorrhage assessment or every other neurocritical feature. RapidAI's emphasis connects imaging results with clinical communication and treatment-transfer workflows. It is therefore best assessed as a hemorrhage pathway component, with the exact modules and notification destinations specified, rather than as a universal replacement for an enterprise radiology worklist platform.

Breadth of imaging versus depth in a pathway

Aidoc is the broadest organizational proposition here because its platform brings several algorithms and interfaces into a common radiology workflow. Harrison.ai Comprehensive Care provides a defined chest-X-ray and non-contrast-head-CT triage package. Rapid ICH begins with suspected hemorrhage on head CT and sits beside other RapidAI neurocritical modules. Those scope differences matter more than a raw count of findings: a hospital prioritizing chest imaging, a mixed emergency worklist and a hemorrhage network may reasonably choose different products even if each can generate urgent notifications.

Where the radiologist sees the result

Aidoc emphasizes PACS worklist marking and a shared results Widget, with communication to downstream care teams. Harrison.ai describes a no-click finding overlay, configurable priority grouping and adjustable thresholds within its PACS/RIS workflow. Rapid ICH documents notification delivery to PACS, email and its mobile app. The practical comparison is where a suspected finding becomes visible and who receives it. A department seeking consistent interaction across algorithms may favor Aidoc; one seeking a defined overlay workflow may favor Harrison.ai; a neurocritical team coordinating through Rapid tools may favor Rapid ICH.

Packaging, indications and price

All three require scoped commercial confirmation rather than a verified public per-user subscription price. Aidoc's algorithm selection, Harrison.ai's regional product package and RapidAI's separately named modules affect what an institution is actually purchasing. Reimbursement figures and vendor outcome studies are different evidence from a software quotation or a comparison of clinical performance. For each product, study eligibility, intended use and local authorization belong to the exact version supplied. The information reviewed here supports workflow comparisons, not a claim that one system has superior sensitivity or improves outcomes in every institution.

Which platform belongs on your shortlist?

Choose Aidoc for an enterprise multi-algorithm workflow, Harrison.ai for a defined CXR/head-CT triage package, and Rapid ICH for hemorrhage-focused alerts in a neurocritical pathway. Match the imaging scope and result destination to the department's actual workflow before comparing commercial proposals.